Constitutive Androstane Receptor induces Ribonucleotide Reductase-M2 expression and maintains hepatocyte ploidy in mice

This study reveals that the nuclear receptor CAR maintains hepatocyte ploidy by directly transactivating the RRM2 gene to drive de novo dNTP synthesis and DNA replication, thereby preventing a shift toward diploid hepatocytes.

The Gist

The Big Picture: The Liver's "Master Switch" and the "Construction Crew"

Imagine your liver is a bustling city. The cells in this city (hepatocytes) are the buildings. Most of these buildings are single-story (diploid), but as the city matures, many buildings expand into massive, multi-story skyscrapers (polyploid/tetraploid). This expansion is normal and actually helps the city handle stress and repair damage later in life.

The scientists in this paper discovered a specific "Master Switch" in the liver called CAR (Constitutive Androstane Receptor). Usually, we think of CAR as a security guard that wakes up when toxins enter the body to start detoxifying them. But this study found that CAR has a second, hidden job: it acts as the architect and foreman that tells the liver cells when to grow bigger and build more floors.

The Problem: What happens when the Switch is broken?

The researchers took a group of mice and turned off their "CAR switch" (creating CAR Knockout mice).

• The Result: Without the switch, the liver cells stayed small and single-story. They failed to grow into the large, multi-story skyscrapers they should have been.
• The Analogy: It's like a construction site where the foreman went on vacation. The workers (cells) didn't get the order to expand, so the city remained a collection of small shacks instead of a thriving metropolis.

The Discovery: The Missing "Bricks"

Why couldn't the cells grow? The researchers realized that to build a bigger cell (or a skyscraper), you need more building materials. In biology, the "bricks" are called dNTPs (DNA building blocks).

The scientists found that the CAR switch directly controls a specific machine called RRM2.

• RRM2 is the Brick Factory: This enzyme is the rate-limiting step, meaning it's the bottleneck. If RRM2 is slow, you can't make enough bricks to build the new DNA needed for cell growth.
• The Connection: When CAR is active, it flips a switch that turns on the RRM2 factory. The factory chugs out bricks (dNTPs), the cells get enough material to duplicate their DNA, and they grow into larger, polyploid cells.
• When CAR is missing: The RRM2 factory shuts down. There are no bricks. The cells can't build new DNA, so they stay small (diploid).

The Experiments: Proving the Theory

The team didn't just guess; they ran several tests to prove this connection:

1. The "Brick Count": They measured the liver cells of normal mice vs. mice without CAR. The normal mice had high levels of DNA bricks (dATP and dTTP). The mice without CAR had very low levels.
2. The "Rescue Mission": They took the mice without the CAR switch (who had no bricks) and manually injected them with a virus that forced their cells to build their own RRM2 factories (overexpressing RRM2).
   • The Result: Even without the CAR switch, the cells suddenly had bricks again! They started growing, their DNA doubled, and they became the large, multi-story cells they were supposed to be.
   • The Lesson: RRM2 is the key. If you give the cells the bricks, they can grow, even if the foreman (CAR) is missing.
3. The "Broken Tool" Test: They tried to use a broken version of the RRM2 machine (a mutant that couldn't actually make bricks). Even if they had the machine, if it was broken, the cells couldn't grow. This proved that the function of making bricks is what matters, not just having the machine sitting there.

Why Does This Matter?

This study changes how we understand liver health:

• Normal Growth: We now know that the liver's natural ability to become "polyploid" (grow extra DNA copies) isn't just random; it's a carefully managed process driven by the CAR switch to ensure there are enough DNA bricks available.
• Disease and Cancer: The liver needs this polyploid state to survive injury. If the CAR-RRM2 connection is broken, the liver might be weaker when it tries to heal. Conversely, if this switch is stuck "ON" (which can happen with certain drugs or toxins), it might force the liver to grow too much, potentially leading to cancer.

Summary Analogy

Think of the liver cell as a house.

• CAR is the Homeowner who decides it's time to add a second story.
• RRM2 is the Construction Crew that actually builds the new floor.
• dNTPs are the Lumber and Bricks.

The paper shows that the Homeowner (CAR) doesn't just yell "Build!"; they specifically call the Construction Crew (RRM2) to order the Lumber (dNTPs). If you fire the Homeowner, the Crew never shows up, and the house stays one story. But if you hire the Crew yourself (overexpressing RRM2), the house gets built anyway, proving the Crew was the most critical part of the process.

Technical Summary

1. Problem Statement and Background

The liver is a metabolic hub where hepatocytes exhibit a unique feature: polyploidy (containing multiple sets of chromosomes). While polyploidy is conserved and linked to metabolic adaptation and stress resistance, the molecular mechanisms connecting metabolic regulation (specifically detoxification) to the maintenance of hepatocyte ploidy remain unclear.

The Constitutive Androstane Receptor (CAR/NR1i3) is a nuclear receptor known as a xenosensor that regulates liver detoxification, nutrient metabolism, and hepatocyte proliferation. Previous studies established that CAR activation (e.g., by the agonist TCPOBOP/TC) leads to hepatomegaly, increased DNA synthesis, and higher ploidy. However, the specific molecular pathway by which CAR orchestrates the increased demand for deoxyribonucleotides (dNTPs) required for DNA synthesis and subsequent polyploidization had not been elucidated.

2. Methodology

The study employed a multi-faceted approach combining in vivo mouse models, in vitro cell culture, molecular biology, and bioinformatics:

• Animal Models:
  • Wild-Type (WT) vs. CAR Knockout (CARKO): Used to determine the basal role of CAR.
  • Pharmacological Activation: Mice were treated with the CAR agonist TCPOBOP (TC) or vehicle (Corn oil).
  • AAV-Mediated Overexpression: Adeno-associated virus (AAV-DJ8) was used to overexpress Rrm2 (RRM2-GFP) or a control (GFP) in WT and CARKO mice to test sufficiency.
• Cell Culture:
  • AML12 cells: An immortalized mouse hepatocyte line used for transfection studies involving CAR, wild-type RRM2 (wtRRM2), and catalytically inactive RRM2 (mutRRM2, Y176F).
  • Primary Hepatocytes: Isolated from WT mice for treatment with hydroxyurea (HU, an RRM2 inhibitor) and TC.
• Molecular & Biochemical Assays:
  • qPCR & Western Blotting: To quantify transcript and protein levels of CAR targets (e.g., Rrm1, Rrm2, Rrm2b) and cell cycle markers.
  • Luciferase Reporter Assays: To validate the functionality of the CAR binding site (DR3 motif) in the Rrm2 promoter.
  • Chromatin Immunoprecipitation (ChIP) & ChIP-seq: To confirm direct binding of CAR to the Rrm2 promoter region.
  • dNTP Pool Analysis: Quantification of hepatic dATP, dTTP, dCTP, and dGTP levels.
  • Ploidy Analysis: Flow cytometry (FACS) of isolated hepatocytes and nuclei stained with Propidium Iodide (PI) or Hoechst to distinguish 2c (diploid), 4c (tetraploid), and 8c+ populations.
  • Proliferation Markers: Immunohistochemistry (IHC) and immunofluorescence (IF) for Ki-67, PCNA, pHH3, and EdU incorporation assays.
  • DNA Damage Assessment: TUNEL staining and H2A.X immunostaining to rule out pathological ploidy changes.

3. Key Contributions and Results

A. CAR is Essential for Maintaining Hepatocyte Ploidy

• Loss of CAR: In CARKO mice, there was a significant shift in hepatocyte ploidy: an increase in diploid (2c) cells and a concomitant reduction in tetraploid (4c) cells. Higher ploidy states (8c, 16c) were less affected, suggesting CAR specifically regulates the transition or maintenance of the 2c/4c balance.
• Transcriptional Regulation: CAR activation upregulated transcription factors involved in polyploidization (E2f1, E2f8) and mitotic entry (AurkB, Plk1).

B. CAR Directly Transactivates Rrm2

• Discovery: Transcriptome mining revealed a robust induction of Rrm2 (Ribonucleotide Reductase Regulatory subunit M2) upon CAR activation. Rrm2 encodes the catalytic subunit of ribonucleotide reductase, the rate-limiting enzyme in de novo dNTP synthesis.
• Direct Binding: Luciferase assays and ChIP-PCR confirmed that CAR binds directly to a specific DR3 motif in the Rrm2 promoter. This binding was conserved in both mouse and human Rrm2 promoters.
• Protein Levels: CAR activation increased RRM2 protein levels but not RRM1 or the DNA damage-induced isoform RRM2b.

C. CAR Upregulates the Entire dNTP Synthesis Pathway

• CAR activation induced transcripts for multiple enzymes in the de novo dNTP synthesis pathway, including ATIC, UMP synthase, CTP synthetase, and dTMP kinase.
• Metabolic Outcome: This transcriptional upregulation resulted in significantly elevated hepatic levels of dATP and dTTP in a CAR-dependent manner. dCTP and dGTP levels remained unchanged, potentially due to high mitochondrial pools or allosteric feedback mechanisms.

D. RRM2 Overexpression Rescues Ploidy Defects in CARKO

• Sufficiency: Overexpressing RRM2 in CARKO mice (via AAV) restored the balance of hepatocyte ploidy, increasing 4c and 8c populations to levels comparable to WT mice.
• Proliferation: RRM2 overexpression in CARKO significantly increased DNA synthesis markers (Ki-67, PCNA, EdU incorporation) and hepatocyte cellular area, leading to an increased liver-to-body weight ratio (hepatomegaly).
• Specificity: The rescue was specific to RRM2; other subunits (Rrm1, Rrm2b) were not compensatorily altered.

E. Catalytic Activity of RRM2 is Required for CAR-Mediated DNA Synthesis

• Inhibition: Treating primary hepatocytes with Hydroxyurea (HU) blocked TC-induced upregulation of cell cycle genes and dNTP synthesis genes.
• Mutant Studies: In AML12 cells, co-transfection of CAR with catalytically inactive RRM2 (Y176F mutant) completely abolished the increase in EdU incorporation normally seen with CAR activation.
• Conclusion: The DNA synthesis and ploidy maintenance driven by CAR are strictly dependent on the catalytic function of RRM2, not just its presence.

4. Significance and Implications

• Novel Mechanism: This study identifies a direct link between a nuclear xenosensor (CAR) and the fundamental machinery of DNA replication (RRM2/dNTP synthesis). It reveals that CAR does not just trigger proliferation signals but actively ensures the metabolic supply (dNTPs) required for DNA synthesis.
• Basal Role of CAR: Beyond its role in acute detoxification responses, CAR plays a basal, constitutive role in maintaining the physiological ploidy distribution of the liver.
• Therapeutic Relevance: Understanding how CAR regulates dNTP pools and ploidy is crucial for liver regeneration, as polyploid hepatocytes are often more resistant to injury. Conversely, since prolonged CAR activation is linked to hepatocellular carcinoma, this pathway highlights a potential vulnerability where dysregulated dNTP synthesis could drive tumorigenesis.
• Metabolic-Genomic Coupling: The findings demonstrate a sophisticated coupling where metabolic sensing (via CAR) directly regulates the genomic stability and replication capacity of hepatocytes through the control of the rate-limiting step in nucleotide biosynthesis.

In summary, the paper establishes that CAR maintains hepatocyte ploidy by directly transactivating Rrm2, thereby increasing the cellular pool of dNTPs necessary for DNA synthesis and the transition to polyploidy.